280 related articles for article (PubMed ID: 35294187)
1. Untangling Mucosal Drug Delivery: Engineering, Designing, and Testing Nanoparticles to Overcome the Mucus Barrier.
Watchorn J; Clasky AJ; Prakash G; Johnston IAE; Chen PZ; Gu FX
ACS Biomater Sci Eng; 2022 Apr; 8(4):1396-1426. PubMed ID: 35294187
[TBL] [Abstract][Full Text] [Related]
2. The role of mucus on drug transport and its potential to affect therapeutic outcomes.
Murgia X; Loretz B; Hartwig O; Hittinger M; Lehr CM
Adv Drug Deliv Rev; 2018 Jan; 124():82-97. PubMed ID: 29106910
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicines for intranasal delivery: understanding the nano-bio interactions at the nasal mucus-mucosal barrier.
Hua T; Li S; Han B
Expert Opin Drug Deliv; 2024 Apr; 21(4):553-572. PubMed ID: 38720439
[TBL] [Abstract][Full Text] [Related]
4. Mucus as a barrier to lipophilic drugs.
Sigurdsson HH; Kirch J; Lehr CM
Int J Pharm; 2013 Aug; 453(1):56-64. PubMed ID: 23727593
[TBL] [Abstract][Full Text] [Related]
5. Mucoadhesive vs. mucopenetrating particulate drug delivery.
Netsomboon K; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2016 Jan; 98():76-89. PubMed ID: 26598207
[TBL] [Abstract][Full Text] [Related]
6. Mucoadhesive versus mucopenetrating nanoparticles for oral delivery of insulin.
Cheng H; Cui Z; Guo S; Zhang X; Huo Y; Mao S
Acta Biomater; 2021 Nov; 135():506-519. PubMed ID: 34487859
[TBL] [Abstract][Full Text] [Related]
7. The role of mucus as an invisible cloak to transepithelial drug delivery by nanoparticles.
García-Díaz M; Birch D; Wan F; Nielsen HM
Adv Drug Deliv Rev; 2018 Jan; 124():107-124. PubMed ID: 29117511
[TBL] [Abstract][Full Text] [Related]
8. The Role of Mucoadhesion and Mucopenetration in the Immune Response Induced by Polymer-Based Mucosal Adjuvants.
Vasquez-Martínez N; Guillen D; Moreno-Mendieta SA; Sanchez S; Rodríguez-Sanoja R
Polymers (Basel); 2023 Mar; 15(7):. PubMed ID: 37050229
[TBL] [Abstract][Full Text] [Related]
9. Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues.
Lai SK; Wang YY; Hanes J
Adv Drug Deliv Rev; 2009 Feb; 61(2):158-71. PubMed ID: 19133304
[TBL] [Abstract][Full Text] [Related]
10. A membrane-free microfluidic approach to mucus permeation for efficient differentiation of mucoadhesive and mucopermeating nanoparticulate systems.
Wright L; Wignall A; Jõemetsa S; Joyce P; Prestidge CA
Drug Deliv Transl Res; 2023 Apr; 13(4):1088-1101. PubMed ID: 36520273
[TBL] [Abstract][Full Text] [Related]
11. "Mucus-on-Chip": A new tool to study the dynamic penetration of nanoparticulate drug carriers into mucus.
Jia Z; Guo Z; Yang CT; Prestidge C; Thierry B
Int J Pharm; 2021 Apr; 598():120391. PubMed ID: 33621642
[TBL] [Abstract][Full Text] [Related]
12. Engineering nanomaterials to overcome the mucosal barrier by modulating surface properties.
Wu L; Shan W; Zhang Z; Huang Y
Adv Drug Deliv Rev; 2018 Jan; 124():150-163. PubMed ID: 28989056
[TBL] [Abstract][Full Text] [Related]
13. Chemical modification of drug molecules as strategy to reduce interactions with mucus.
Araújo F; Martins C; Azevedo C; Sarmento B
Adv Drug Deliv Rev; 2018 Jan; 124():98-106. PubMed ID: 28964880
[TBL] [Abstract][Full Text] [Related]
14. Mucus-Penetrating Nanosuspensions for Enhanced Delivery of Poorly Soluble Drugs to Mucosal Surfaces.
Yu T; Chisholm J; Choi WJ; Anonuevo A; Pulicare S; Zhong W; Chen M; Fridley C; Lai SK; Ensign LM; Suk JS; Hanes J
Adv Healthc Mater; 2016 Nov; 5(21):2745-2750. PubMed ID: 27717163
[TBL] [Abstract][Full Text] [Related]
15. PEGylation for enhancing nanoparticle diffusion in mucus.
Huckaby JT; Lai SK
Adv Drug Deliv Rev; 2018 Jan; 124():125-139. PubMed ID: 28882703
[TBL] [Abstract][Full Text] [Related]
16. Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development.
Wong TW; Dhanawat M; Rathbone MJ
Expert Opin Drug Deliv; 2014 Sep; 11(9):1419-34. PubMed ID: 24960192
[TBL] [Abstract][Full Text] [Related]
17. Enhancing nanoparticle penetration through airway mucus to improve drug delivery efficacy in the lung.
Chen D; Liu J; Wu J; Suk JS
Expert Opin Drug Deliv; 2021 May; 18(5):595-606. PubMed ID: 33218265
[No Abstract] [Full Text] [Related]
18. Models to evaluate the barrier properties of mucus during drug diffusion.
Liu L; Tian C; Dong B; Xia M; Cai Y; Hu R; Chu X
Int J Pharm; 2021 Apr; 599():120415. PubMed ID: 33647411
[TBL] [Abstract][Full Text] [Related]
19. Technological strategies to estimate and control diffusive passage times through the mucus barrier in mucosal drug delivery.
Newby JM; Seim I; Lysy M; Ling Y; Huckaby J; Lai SK; Forest MG
Adv Drug Deliv Rev; 2018 Jan; 124():64-81. PubMed ID: 29246855
[TBL] [Abstract][Full Text] [Related]
20. Advances in mucoadhesion and mucoadhesive polymers.
Khutoryanskiy VV
Macromol Biosci; 2011 Jun; 11(6):748-64. PubMed ID: 21188688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
